Denials Are Rising, but That Is Not the Root Cause of Revenue Leakage

Over the past year, one topic has come up in nearly every conversation I’ve had with specialty practice professionals, executives, and revenue cycle leaders. Denials are up – in many specialties approaching 15%-20% – and for many organizations it feels like a constant effort just to keep pace.

When you move beyond the headline metric and spend time inside the workflows driving those outcomes, a different picture starts to emerge. Denials are not the core issue behind practices missing out on revenue opportunities. They are the output of something deeper, and how an organization defines that distinction ultimately shapes how it responds.

Denials Are Predictable, Not Random

There is a natural tendency to attribute rising denials to external pressure, particularly shifting payer behavior, evolving policies, and increasing scrutiny. While those factors are real, they are only part of the story. What is far more consistent, and far more actionable, is the repeatability of denial patterns.

Join the "RCM Survival" webinar series Sept. 16 & Dec. 2

The same categories of denials appear across the same procedures, the same payers, and often the same breakdown points in the workflow. Eligibility is not fully validated at intake. Authorizations are incomplete or misaligned to the level of care. Documentation does not support the claim as submitted. Coding fails to capture the full clinical picture.

These are not isolated mistakes; they are repeatable process failures showing up with predictable consistency. That predictability is where the opportunity sits, but it is also where many specialty healthcare practices struggle. Internal teams are often too close to their own processes to see patterns clearly across the full life cycle, particularly when data is fragmented across systems and responsibilities are divided across departments.

This is where experienced revenue cycle partners can materially change the equation. With visibility across a broader set of providers, specialties, and payer interactions, they can identify patterns faster, benchmark performance more accurately, and implement workflow changes that are grounded in proven outcomes. There’s clear value gained from additional capacity and also from perspective, discipline, and the ability to translate recurring issues into operational fixes that hold.

Small Breakdowns Create Systemic Rework

What makes denial management particularly challenging is the underlying issues rarely present themselves as large, isolated failures. Instead they emerge as small, seemingly manageable breakdowns, issues that can often be addressed in the moment but overlooked as recurring patterns over time. A missed authorization may be appealed, though not always successfully overturned. An eligibility issue can be corrected, only to reveal that the patient’s new policy required a referral or prior authorization that was never obtained. A documentation deficiency can often be resolved through a provider addendum or clarification.

Viewed individually, each case appears recoverable. At scale, however, those small breakdowns compound. Work queues expand as rework becomes the norm rather than the exception. Teams spend increasing amounts of time chasing revenue that should have been captured correctly the first time. Cash flow slows, not because revenue is not being generated, but because it is being delayed, diluted, or lost through preventable friction.

Prior authorization failures are a clear example of this dynamic. When authorization is not properly secured or aligned on the front end, every step that follows becomes more complex. Even successful appeals require time, coordination, and resources that could have been avoided with tighter upstream controls. The same pattern applies to documentation gaps that surface during payer review or coding inaccuracies that limit reimbursement after submission.

Practices that effectively reduce this rework do so by tightening processes at the source. Increasingly, that includes partnering with revenue cycle organizations that bring standardized workflows, clearer accountability, and continuous monitoring into these early stages. Instead of relying on downstream correction, they introduce upstream precision, which changes both the volume and the nature of denials that occur.

The Industry Is Still Operating Reactively

Despite the predictability of these issues, most specialty practices remain structurally reactive. Reporting is centered on denial rates, appeal success, and AR performance. Teams are organized to manage what has already gone wrong, often with impressive efficiency, but without a corresponding investment in preventing those issues from occurring in the first place.

That gap between reaction and prevention is where performance begins to diverge. Organizations that are improving denial rates in a meaningful way are not simply working denials faster. They are rethinking where accountability sits across the life cycle. Intake processes are being redesigned to eliminate eligibility gaps before they occur. Authorization workflows are being standardized with clearer ownership and escalation paths. Clinical documentation is being aligned more intentionally with payer requirements, reducing ambiguity before claims are ever submitted.

In many cases, these changes are accelerated through the involvement of revenue cycle partners who can embed structure and consistency across functions that have historically operated in silos. The result is not just fewer denials, but a more stable and predictable revenue cycle overall.

The Real Opportunity to Prevent Revenue Loss

Reframing denials as a symptom rather than the problem itself shifts the conversation in a substantive way. It moves the focus away from managing volume and toward understanding causality. It forces a more honest assessment of how much revenue loss is actually preventable and where intervention will have the greatest impact.

Avoidable denials, prior authorization failures, and documentation gaps are not rare anomalies that can be dismissed as occasional mistakes. Rather, they are recurring, measurable drivers of both revenue loss and operational inefficiency. Organizations that address them at the source, through a combination of internal alignment and the right external expertise, are the ones creating separation in an increasingly constrained environment.

Denials will always exist. But at their current scale, they are not inevitable. Shifting from reaction to prevention is often where the greatest opportunity for improvement begins.

This blog post is part of a series on revenue cycle management produced in partnership with Assembly Health.

About the Author

Samantha Akhtarzandi is the Head of Physician RCM & Executive VP of Growth, Physician RCM at Assembly Health. In this role, she leads strategic growth initiatives, supports enterprise sales, manages key client relationships, and serves as a trusted advisor to healthcare organizations seeking to optimize financial performance and operational efficiency across the revenue cycle.

Prior to joining Assembly Health, Samantha was the Founder and CEO of Doctors’ Choice Medical Services, where she successfully built and scaled a high-performing RCM organization. Samantha is known for her strategic insight, client-centric approach, and ability to translate complex revenue cycle challenges into actionable solutions that drive growth and long-term value.